Twist Bioscience Corporation reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was USD 75.3 million compared to USD 60.18 million a year ago. Net loss was USD 45.49 million compared to USD 59.16 million a year ago. Basic loss per share from continuing operations was USD 0.79 compared to USD 1.04 a year ago.
For the six months, sales was USD 146.8 million compared to USD 114.42 million a year ago. Net loss was USD 88.5 million compared to USD 100.98 million a year ago. Basic loss per share from continuing operations was USD 1.54 compared to USD 1.78 a year ago.